U.S. Physical Therapy reported strong Q3 2021 results with revenue up 15.6% year-over-year, driven by robust patient volumes. The company's net income attributable to USPH shareholders was $10.0 million, and adjusted EBITDA, excluding Relief Funds, was $19.9 million, a 1.8% increase compared to the same period last year.
Operating Results per diluted share, excluding Relief Funds, was $0.85, the same as in Q3 2020 and 21.4% higher than Q3 2019.
Adjusted EBITDA, excluding Relief Funds, was $19.9 million, 1.8% higher than Q3 2020 and 17.6% higher than Q3 2019.
Net patient revenue from physical therapy operations was $112.3 million, a 16.5% increase from Q3 2020.
Industrial injury prevention services revenue was $10.5 million, representing a 4.8% increase over Q3 2020.
The company did not provide forward guidance in this earnings report.